About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prospective Study FNB, Is It Time To Abandon Cytological Assessment

Prospective Study FNB, Is It Time To Abandon Cytological Assessment

NCT04165018·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Baylor College of Medicine

Age

18–100

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patient is greater than or equal to 18 years of age
Patient is referred to EUS-FNB for pancreatic mass lesions

You may not be if

Patient is younger than 18 years of age
Patient refused and/or unable to provide consent
Patient is a pregnant woman

The record

StatusCompleted

PhaseNo phase

Taking part52

StartedApr 2021

UpdatedMar 24, 2026

Conditions

Pancreatic Neoplasms

Where2

Baylor College of Medicine
Houston, Texas, United States
Baylor St. Lukes Medical Center (BSLMC)
Houston, Texas, United States